Search results
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
WSB-TV 2 Atlanta· 6 days agoWASHINGTON — (AP) — Government advisers Wednesday said it’s time to update the recipe for the COVID...
Spotlight on Pfizer: Analyzing the Surge in Options Activity - Pfizer (NYSE:PFE)
Benzinga· 1 day agoWhile it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal ...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
Houston Chronicle· 6 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
Moderna's COVID-flu combo shot outperformed existing vaccines in a late-stage trial
Quartz· 1 day agoModerna said on Monday that its experimental combination vaccines against COVID-19 and the flu...
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 7 days agoThe FDA’s independent Vaccines and Related Biological Products Advisory Committee voted unanimously...
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say
Reuters· 6 days agoCOVID-19 vaccine makers said data from animals studies showed their 2024-25 shots targeting the JN.1...
Moderna's combo Covid, flu vaccine meets goals in late-stage study - Boston Business Journal
The Business Journals· 1 day agoModerna Inc. is making steady headway on its plan to launch all four products from its respiratory ...
COVID Shots for JN.1 Variant Neutralize Newer Strains, Vaccine Makers Say
US News & World Report· 6 days agoFood and Drug Administration's advisers on Wednesday. The FDA panel will vote to recommend if companies should target the JN.1 variant when the companies update their vaccines
Will there be a new Covid vaccine in the fall?
NBC Universal via AOL· 6 days ago"Will we regret not having been a little bit closer?" he added. ... will kickstart production of the updated shots, which will be distributed as part of...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 4 days agoIt will be important to watch how Pfizer stock performs as the company shores up its pipeline and...